… for advanced or metastatic thyroid carcinomas have been of … To date, only selective inhibitors
of BRAF have entered … KIT-inhibitor imatinib, use of selective BRAF inhibitors has not yet …

… are mostly associated with medullary thyroid carcinoma [92]. … candidates for treatment with
selective inhibitors of RET … fusion-positive non-medullary thyroid carcinoma in a phase 1–2 …

… thyroid follicular carcinoma with massive metastatic lesions. In such a situation, selective
treatment is required to control thyroid … metastases of follicular thyroid carcinoma and show that …

… cases of papillary thyroid carcinoma with biopsy-proven lymph node metastasis. The purpose
of this study was to evaluate the efficacy and safety of super-selective neck dissection for …

The Clinical Practice Guidelines for the Management of Thyroid Carcinoma represent the
third set of thyroid disease management guidelines produced by the American Association of …

… There are still some limitations in the selective use of novel compounds. There might be
several potential targets in a given tumor, and most compounds can hit multiple targets, so the …

… We selectively use RAI remnant ablation when a primary tumor confined to the thyroid is
between 1 and 4 cm, with or without lymph node metastases, when the combination of age, …

Background The understanding of biology of well-differentiated thyroid cancer has improved
in the last two decades with the detailed understanding of prognostic factors and risk group …

… Moreover, many patients with relatively small thyroid carcinomas had serum Tg … Tg was of
limited use for the initial diagnosis of thyroid carcinoma. Similarly, thyroid cancer patients who …

… The treatment strategy was selective use of less extensive therapy in selected low-risk … to
lymph node status and dissection in papillary thyroid carcinoma (PTC). During the study period, …